Board of Directors
Erez AminovChairman and Chief Executive Officer
Erez Aminov is the Chairman and Chief Executive Officer of Telomir Pharmaceuticals, Inc. (NASDAQ: TELO), a clinical-stage biotechnology company developing Telomir-Zn, a novel oral epigenetic therapy for patients with advanced triple-negative breast cancer (TNBC). Under his leadership, the company advanced Telomir-Zn through preclinical development to FDA IND clearance for a Phase 1/2 clinical trial.
Mr. Aminov leads Telomir’s corporate strategy, financing, business development, intellectual property, and clinical execution. He has successfully structured and executed multiple strategic transactions, including worldwide licensing agreements, acquisitions of global development and commercialization rights, and business development initiatives that have strengthened the Company’s intellectual property portfolio.
Mr. Aminov also serves as Chairman and Chief Executive Officer of MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), where he has overseen the advancement of one clinical-stage development program together with additional preclinical pipeline assets and successfully led the company through its initial public offering.
Before leading public biotechnology companies, Mr. Aminov worked as a consultant, advising on corporate strategy, business development, and strategic transactions within the biotechnology sector.
Mr. Aminov holds a Bachelor of Arts in Accounting from Touro University.
Mr. Aminov leads Telomir’s corporate strategy, financing, business development, intellectual property, and clinical execution. He has successfully structured and executed multiple strategic transactions, including worldwide licensing agreements, acquisitions of global development and commercialization rights, and business development initiatives that have strengthened the Company’s intellectual property portfolio.
Mr. Aminov also serves as Chairman and Chief Executive Officer of MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA), where he has overseen the advancement of one clinical-stage development program together with additional preclinical pipeline assets and successfully led the company through its initial public offering.
Before leading public biotechnology companies, Mr. Aminov worked as a consultant, advising on corporate strategy, business development, and strategic transactions within the biotechnology sector.
Mr. Aminov holds a Bachelor of Arts in Accounting from Touro University.
Matthew P. Del Giudice, M.D.Director
Dr. Matthew P. Del Giudice, age 42, has practiced as a radiologist since 2014. He currently serves as a general overnight emergency radiologist at the Cleveland Clinic. Since March 2024, he has also served as a director of MIRA Pharmaceuticals, Inc. (Nasdaq: MIRA). Prior to joining the Cleveland Clinic, from March 2021 to May 2022, Dr. Del Giudice was a general radiologist with Radiology and Imaging Specialists in Phoenix, Arizona. From July 2015 to February 2021, Dr. Del Giudice was a radiologist with Radiology Partners Phoenix, and from July 2014 to June 2015, he practiced as a musculoskeletal radiologist at the University of Arizona Health Sciences Center – Tucson.
Dr. Del Giudice received his B.S. from the University of Illinois at Urbana-Champaign, his M.D. from Loyola University Stritch School of Medicine, completed his radiology residency at Loyola University Medical Center, and his musculoskeletal radiology fellowship at the University of Arizona Health Sciences Center – Tucson. Dr. Del Giudice is licensed to practice medicine in Florida and Ohio. We believe that Dr. Del Giudice is qualified to serve as one of our directors based on his extensive experience as a radiologist.
Dr. Del Giudice received his B.S. from the University of Illinois at Urbana-Champaign, his M.D. from Loyola University Stritch School of Medicine, completed his radiology residency at Loyola University Medical Center, and his musculoskeletal radiology fellowship at the University of Arizona Health Sciences Center – Tucson. Dr. Del Giudice is licensed to practice medicine in Florida and Ohio. We believe that Dr. Del Giudice is qualified to serve as one of our directors based on his extensive experience as a radiologist.
Matthew Pratt Whalen, CPADirector
Matthew Pratt Whalen, CPA, age 45, is a Certified Public Accountant with over two decades of experience in public accounting and corporate finance. Mr. Whalen currently serves as the Chief Financial Officer of Power Digital Marketing Inc., an industry leading digital marketing agency, where he has driven significant revenue growth and led key financial transactions. Specifically, Mr. Whalen oversees the finance team, manages tax and audit relationships, and handles treasury management. Prior to joining Power Digital, from 2010 to May 2021, Mr. Whalen was the Chief Financial Officer of MRC Smart Technology Solutions, a subsidiary of Xerox Corporation where he played a pivotal role in growing the company’s revenue and managed diverse teams across multiple departments. Mr. Whalen holds a B.A. in Accounting from the University of San Diego and is a Certified Public Accountant in California. Mr. Whalen has also served on the Finance Committee of United Way San Diego. We believe that Mr. Whalen is qualified to serve as one of our directors based on his extensive experience in finance and as a Certified Public Accountant. Mr. Whalen has also served as a director of MIRA Pharmaceuticals, Inc. (Nasdaq:MIRA).
Ned MacPhersonDirector
Ned MacPherson, age 36, currently serves as Chief Growth Officer for Power Digital, an industry leading digital marketing agency. Since March 2024, he has also served as a director of MIRA Pharmaceuticals, Inc. (Nasdaq: MIRA). Prior to joining Power Digital, from May 2016 to December 2023, he served as CEO and Head of Growth for Endrock Growth & Analytics, a company he founded and sold to Power Digital. Prior to founding Endrock Growth & Analytics, Mr. MacPherson held senior marketing and leadership positions at sunglass maker Prive Revaux (March 2018 to April 2020), curated meal company Menud (October 2014 to April 2018) and Rejuvenetics, LLC, a distributor of health and wellness products (December 2012 to March 2016).
Mr. Macpherson holds a BA in Economics from Gettysburg College. We believe that Mr. MacPherson is qualified to serve as one of our directors based on his extensive experience assisting growth for early-stage companies.
Mr. Macpherson holds a BA in Economics from Gettysburg College. We believe that Mr. MacPherson is qualified to serve as one of our directors based on his extensive experience assisting growth for early-stage companies.